Cargando…
Targeting the Checkpoint to Kill Cancer Cells
Cancer treatments such as radiotherapy and most of the chemotherapies act by damaging DNA of cancer cells. Upon DNA damage, cells stop proliferation at cell cycle checkpoints, which provides them time for DNA repair. Inhibiting the checkpoint allows entry to mitosis despite the presence of DNA damag...
Autores principales: | Benada, Jan, Macurek, Libor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4598780/ https://www.ncbi.nlm.nih.gov/pubmed/26295265 http://dx.doi.org/10.3390/biom5031912 |
Ejemplares similares
-
Checkpoint recovery in cells: how a molecular understanding can help in the fight against cancer
por: Medema, René H., et al.
Publicado: (2011) -
Inhibition of WIP1 phosphatase sensitizes breast cancer cells to genotoxic stress and to MDM2 antagonist nutlin-3
por: Pechackova, Sona, et al.
Publicado: (2016) -
Polo-like kinase 1 inhibits DNA damage response during mitosis
por: Benada, Jan, et al.
Publicado: (2015) -
WIP1 phosphatase as pharmacological target in cancer therapy
por: Pecháčková, Soňa, et al.
Publicado: (2017) -
Gain-of-function mutations of PPM1D/Wip1 impair the p53-dependent G1
checkpoint
por: Kleiblova, Petra, et al.
Publicado: (2013)